We’re pushing to deliver a new treatment for Parkinson’s by the end of 2024. And we’re determined to develop a cure in the shortest possible time. We’ve already made vital discoveries that have revolutionised our understanding of Parkinson’s and the brain.
Correspondingly, what is the newest drug for Parkinson’s?
Safinamide (Xadago) is the newest drug approved for Parkinson’s disease. It is used as adjunct therapy to levodopa/carbidopa (Sinemet and others) when Parkinson’s symptoms are not well controlled by that medication alone.
Besides, what’s New in Parkinson’s treatment?
The US Food and Drug Administration (FDA) has approved GOCOVRI® (amantadine) extended-release tablets for people with Parkinson’s. Manufactured by Adamas Pharmaceuticals, GOCOVRI is approved as an adjunctive treatment to levodopa/carbidopa in people with Parkinson’s who experience OFF episodes.